Cornerstone Capital, Inc. Merck & Co., Inc. Transaction History

Cornerstone Capital, Inc.

$988 Million
Q2 2024

A detailed history of Cornerstone Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cornerstone Capital, Inc. holds 5,743 shares of MRK stock, worth $681,062. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,743

Previous 4,573 25.58%

Holding current value

$681,062

Previous $603,000 17.74%

% of portfolio

0.07%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$123.8 - $132.96 $144,846 - $155,563	1,170 Added 25.58%	5,743 $710,000
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $75,870 - $88,406	-670 Reduced 12.78%	4,573 $603,000
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $27,796 - $30,869	-270 Reduced 4.9%	5,243 $539,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $62,175 - $69,375	-604 Reduced 9.87%	5,513 $586,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $92,773 - $118,948	-1,061 Reduced 14.78%	6,117 $678,000
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $28,655 - $32,191	339 Added 4.96%	7,178 $618,000
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $12,129 - $13,596	-165 Reduced 2.36%	6,839 $561,000
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $64,979 - $81,395	-899 Reduced 11.38%	7,004 $537,000
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $10,823 - $11,903	-151 Reduced 1.87%	7,903 $594,000
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $10,616 - $11,743	151 Added 1.91%	8,054 $626,000
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $72,509 - $85,408	-1,053 Reduced 11.76%	7,903 $609,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $97,607 - $108,324	1,360 Added 17.9%	8,956 $733,000
Q3 2020 Oct 27, 2020	BUY	$73.18 - $82.95 $109,770 - $124,425	1,500 Added 24.61%	7,596 $630,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $22,182 - $25,240	315 Added 5.45%	6,096 $471,000
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $16,790 - $23,272	-265 Reduced 4.38%	5,781 $445,000
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $46,160 - $52,086	-595 Reduced 8.96%	6,046 $550,000
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $15,216 - $16,586	-200 Reduced 2.92%	6,641 $559,000
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $62,622 - $71,424	-900 Reduced 11.63%	6,841 $569,000
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $11,417 - $13,249	-175 Reduced 2.21%	7,741 $591,000
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $1,270 - $1,493	25 Added 0.32%	7,916 $481,000
Q1 2018 May 08, 2018	SELL	$50.96 - $59.23 $2,802 - $3,257	-55 Reduced 0.69%	7,891 $430,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $466,191 - $501,630	7,946	7,946 $509,000

Others Institutions Holding MRK

# of Institutions

3,825

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $300B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Capital, Inc. with notifications on news.

Account

Cornerstone Capital, Inc. Merck & Co., Inc. Transaction History